PFGIA
LRMR icon

Patriot Financial Group Insurance Agency’s Larimar Therapeutics LRMR Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18
Closed – – 1931
2020
Q3 		$0 Hold
18
– – ﹤0.01% 1768
2020
Q2 		$0 Sell
18
-1
-5% -$12 ﹤0.01% 1763
2020
Q1 		$0 Hold
19
– – ﹤0.01% 1660
2019
Q4 		$0 Hold
19
– – ﹤0.01% 1389
2019
Q3 		$0 Hold
19
– – ﹤0.01% 1397
2019
Q2 		$1K Hold
19
– – ﹤0.01% 1270
2019
Q1 		$1K Buy
+19
New +$974 ﹤0.01% 1136

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Patriot Financial Group Insurance Agency's LRMR Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Larimar Therapeutics (LRMR) in Q4 2020, closing a stake of 18 shares.

Patriot Financial Group Insurance Agency first reported a position in LRMR in Q1 2019 and held it in 7 quarters. The position peaked at $1K in Q2 2019. 43 funds tracked by Wall St. Rank hold LRMR as of Q4 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Larimar Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 18 Larimar Therapeutics shares in Q4 2020.
  • Patriot Financial Group Insurance Agency first reported a position in Larimar Therapeutics in Q1 2019 and held it in 7 quarters.
  • Patriot Financial Group Insurance Agency's Larimar Therapeutics position peaked at $1K in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.